Whanin Pharmaceutical Co., Ltd. logo

Whanin Pharmaceutical Co., Ltd. (016580)

Market Closed
15 Jun, 06:30
KRX SM KRX SM
10,240. 00
+20
+0.1957%
173.74B Market Cap
- P/E Ratio
1,200% Div Yield
22,673 Volume
- Eps
10,220
Previous Close
Add Transaction
Day Range
10,200 10,430
Year Range
9,850 13,210
Want to track 016580 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

016580 closed today higher at ₩10,240, an increase of 0.1957% from yesterday's close, completing a monthly decrease of -1.633% or -₩170. Over the past 12 months, 016580 stock lost -9.5406%.
016580 pays dividends to its shareholders, with the most recent payment made on Apr 16, 2026. The next estimated payment will be in In 10 months on Apr 16, 2027 for a total of ₩300.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Whanin Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Apr 14, 2010.
The company's stock is traded on one exchange.

016580 Chart

People also search for

Tk Chemical Corp.
1,792
+1.4723%
H.S. Industries Co. Ltd.
2,780
+1.0909%
Motrex Co. Ltd.
7,020
+1.1527%
BYC Co Limited Preferred Stock
25,550
+0.9881%
Digital Daesung Co., Ltd.
7,860
-0.3802%

Whanin Pharmaceutical Co., Ltd. (016580) FAQ

What is the stock price today?

The current price is ₩10,240.00.

On which exchange is it traded?

Whanin Pharmaceutical Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 016580.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1,200%.

What is its market cap?

As of today, the market cap is 173.74B.

Has Whanin Pharmaceutical Co., Ltd. ever had a stock split?

Whanin Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Apr 14, 2010.

Whanin Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Wonbum Lee CEO
KRX SM Exchange
KR7016580003 ISIN
South Korea Country
579 Employees
29 Dec 2025 Last Dividend
14 Apr 2010 Last Split
- IPO Date

Overview

Whan In Pharm Co., Ltd., established in 1978, plays a vital role in South Korea's pharmaceutical industry by developing, manufacturing, and marketing a wide range of pharmaceutical products. With a strong commitment to improving healthcare and patient outcomes, Whan In Pharm has established itself as a notable entity. Headquartered in Seoul, South Korea, the company leverages its extensive experience and research capabilities to innovate and supply medications catering to various medical conditions.

Products and Services

  • Anti-depressants: Medications designed to alleviate symptoms of depression, improving mood, and emotional well-being.
  • Anti-psychotics: Treatments aimed at managing psychotic symptoms such as hallucinations and delusions, primarily for conditions like schizophrenia.
  • Nootropics and Anti-dementia: Products focused on enhancing cognitive function and slowing the progression of dementia-related diseases.
  • Anti-epileptics: Drugs used to prevent or control seizures in patients with epilepsy or similar conditions.
  • Cardiovascular: A range of medications aimed at treating heart and blood vessel related conditions, including hypertension and heart failure.
  • Gastrointestinal: Medications directed at treating various disorders of the gastrointestinal tract, such as acid reflux, ulcers, and irritable bowel syndrome.
  • Antibiotics: Drugs that fight bacterial infections, crucial in treating various infectious diseases.
  • Antiviral agents: Medications used to treat viral infections by inhibiting the development of the virus within the host.
  • Antihistamines: Treatments that relieve symptoms of allergic reactions, such as sneezing, itching, and watery eyes.
  • Anti-inflammatory and Analgesics: Medications that both reduce inflammation and relieve pain. Ideal for conditions including arthritis and muscle aches.
  • Metabolic Disorders: Treatments for diseases that affect metabolism, such as diabetes and thyroid disorders.
  • Respiratory: Drugs aimed at treating respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and allergies.
  • Central Nervous System: Medications focused on treating conditions affecting the brain and nerves, including Parkinson’s disease and multiple sclerosis.
  • Other drug products: A variety of other pharmaceuticals that cater to a wide range of health issues, further emphasizing Whan In Pharm's commitment to comprehensive healthcare solutions.

Contact Information

Address: Whanin Building, 11
Phone: 82 2 405 3000